THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY

• Main Authors: Nader Farajollah (Author), Octavian Marius Dincă (Author), George Cristian Vlădan (Author), Tiberiu Niță (Author), Lavinia Cristina Pădurariu (Author), Alexandru Bucur (Author)
• Format: Book
• Published: Romanian Society of Oral Rehabilitation, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive drugs - Bisphosphonates (BPs) and RANKL inhibitor (denosumab) - prescribed for treatment of bone malignancies and severe osteoporosis. Non-surgical treatment may be a valid option for MRONJ in patients inel...